Nanoparticles in Cellular Drug Delivery
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (30 June 2024) | Viewed by 5513
Special Issue Editors
Interests: mesoporous silica nanoparticles; drug formulation; 3D printing; tissue engineering; nanomedicine
Special Issues, Collections and Topics in MDPI journals
Interests: theranostic nanoparticles; functional assembly; drug nanocarriers; nanocatalysts; combined therapy; nano-bio interfaces; stimuli responsiveness
Special Issue Information
Dear Colleagues,
Since the millennium shift, there has been an explosive development in the intracellular delivery of active agents, especially with the aid of nanoparticles (NPs). Diverse drug formulations have emerged by combining technologies of host–guest interactions, self-assembly, aggregation/clustering, encapsulation, loading, and so forth at molecular and nanometer scale. NPs can flexibly be designed to overcome the challenges associated with intracellular delivery, including crossing of the cell membrane, protection of sensitive agents during delivery, and the integration of controlled release functions into the carrier system. Drug action targets and activation pathways can be accessed/triggered more efficiently and specifically to realize precise therapy based on various mechanisms such as modification of biomacromolecules and their interaction networks, intervention of organelle functions, reprogramming of energy metabolism, remodeling of tumor microenvironment, reversion of immunosuppression, etc. The more recent surge in biological drugs (peptides, proteins, genes) in particular highlighted the importance of effective cellular delivery systems, boosted by the success of the Moderna and Pfizer/BioNTech COVID-19 nanovaccines. Moreover, the combination of externally applied energy and endogenous triggers is now frequently employed to further improve the selectivity of the NP-facilitated drug treatment or boost the therapeutic outcomes. Although many challenges have been solved, plenty remain—especially in view of the efficacy and translation of the more novel technologies.
This Special Issue is dedicated to presenting the recent advances relevant to Nanoparticles in Cellular Drug Delivery, ranging from synthesis methods and regulatory aspects to their detailed physicochemical characterization, interactions at the nano–bio interfaces, mechanisms of cell fate decisions, and performance in vitro and in vivo, especially for controlled and/or targeted drug delivery applications.
Prof. Dr. Jessica M. Rosenholm
Prof. Dr. Jixi Zhang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomedicine
- intracellular delivery
- controlled release
- cellular targeting
- delivery of biologicals
- gene transfection
- precision therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
